Antigen escape is also seen in solid tumours, as shown in IL13Ra2 targeting CAR-T strategies for glioblastoma by Brown et al. (2016) tumour IL13Ra2 recurrence decreased significantly as treatment progressed (Figure 2). This evidence concerns the gene IL13RA2 and neoplasm.